SCHEMBL6169784

SCHEMBL6169784

CCOC(=O)C(OC(C)=O)(C(=O)OCC)c1c(C(=O)c2ccc(Cl)cc2)[nH]c2ccc(F)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 6/20 0.39
KMT2A Q03164 4/20 0.39
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 5/20 0.39
CYP1A2 P05177 1/20 0.39
XBP1 P17861 1/20 0.39
CYP2C19 P33261 1/20 0.39
KDM4E B2RXH2 4/20 0.37
LMNA P02545 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
ALOX5 P09917 1/20 0.37
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171751 0.92 ALDH1A1 (0.46) ALOX15KMT2AHPGDSMN1; SMN2MEN1
SCHEMBL6169500 0.90 MAPT (0.44) ALOX15KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6171922 0.90 L3MBTL1 (0.41) ALOX15KMT2AHPGDSMN1; SMN2MEN1
SCHEMBL6171200 0.89 ALOX15 (0.50) ALOX15
SCHEMBL6172685 0.86 ALOX15 (0.51) ALOX15
SCHEMBL6168370 0.83 ALDH1A1 (0.46) ALOX15KMT2AHPGDSMN1; SMN2MEN1
SCHEMBL6172675 0.83 ALOX15 (0.41) ALOX15
SCHEMBL6168269 0.82 ALOX15 (0.49) ALOX15
SCHEMBL6168523 0.82 ALOX15 (0.45) ALOX15HPGDALDH1A1CYP1A2XBP1
SCHEMBL6170441 0.82 ALDH1A1 (0.45) ALOX15KMT2AHPGDSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed